Cargando…
Exploring the application of sildenafil for high-fat diet-induced erectile dysfunction based on interleukin-18-mediated NLRP3/Caspase-1 signaling pathway
BACKGROUND: Inflammation is a key risk factor for heart disease and has also been linked to erectile dysfunction (ED). Sildenafil is a phosphodiesterase type 5 inhibitor with a strong antioxidant effect. Interleukin (IL)-18 is a proinflammatory factor. Excessive production and release of IL-18 disru...
Autores principales: | Zhu, Bingbing, Niu, Yangjiu, Niu, Lipan, Zhang, Xijia, Liu, Fengxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460117/ https://www.ncbi.nlm.nih.gov/pubmed/37636019 http://dx.doi.org/10.1093/sexmed/qfad044 |
Ejemplares similares
-
Pyroptosis and inflammation‑mediated endothelial dysfunction may act as key factors in the development of erectile dysfunction (Review)
por: Zhu, Bingbing, et al.
Publicado: (2023) -
Sildenafil in the treatment of erectile dysfunction: an overview of the clinical evidence
por: Hatzimouratidis, Konstantinos
Publicado: (2006) -
Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond
por: Ghofrani, Hossein A., et al.
Publicado: (2006) -
Long-term safety and effectiveness of sildenafil citrate in men with erectile dysfunction
por: McMurray, James G, et al.
Publicado: (2007) -
Coronary artery flow reserve in diabetics with erectile dysfunction using sildenafil
por: Dietz, Ulrich, et al.
Publicado: (2003)